Log in to save to my catalogue

Comprehensive analysis of clinical prognosis and molecular immune characterization of tropomyosin 4...

Comprehensive analysis of clinical prognosis and molecular immune characterization of tropomyosin 4...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2526304586

Comprehensive analysis of clinical prognosis and molecular immune characterization of tropomyosin 4 in pancreatic cancer

About this item

Full title

Comprehensive analysis of clinical prognosis and molecular immune characterization of tropomyosin 4 in pancreatic cancer

Publisher

New York: Springer US

Journal title

Investigational new drugs, 2021-12, Vol.39 (6), p.1469-1483

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Pancreatic cancer (PC) is one of the most lethal human solid malignancies with devastating prognosis, making biomarker detection considerably important. Immune infiltrates in microenvironment is associated with patients’ survival in PC. The role of Tropomyosin 4 (TPM4) gene in PC has not been reported. Our study first identifies TPM4 expression and...

Alternative Titles

Full title

Comprehensive analysis of clinical prognosis and molecular immune characterization of tropomyosin 4 in pancreatic cancer

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2526304586

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2526304586

Other Identifiers

ISSN

0167-6997,1573-0646

E-ISSN

1573-0646

DOI

10.1007/s10637-021-01128-z

How to access this item